XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes
 9 Months Ended
Mar. 26, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

13. Income Taxes

We account for income taxes under the asset and liability method. The provision for income taxes recorded in interim periods is based on our estimate of the annual effective tax rate applied to year-to-date income before provision for income taxes, adjusted for discrete items required to be recognized in the period in which they are incurred. In each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, we make a cumulative adjustment in that quarter. Our quarterly tax provision and our quarterly estimate of the annual effective tax rate can be subject to volatility due to several factors, including our ability to accurately forecast annual income before provision for income taxes in each of the tax jurisdictions in which we operate.

The provision for income taxes of $24.4 million and $10.4 million for the three months ended March 26, 2022 and March 27, 2021, respectively, represented estimated federal, foreign, and state income taxes. The effective tax rate for the three months ended March 26, 2022 diverged from the combined U.S. federal and state statutory tax rate primarily because of the benefit of income taxed at lower rates, research credits and foreign tax credits, partially offset by foreign withholding taxes, non-deductible officer compensation and global intangible low-taxed income, or GILTI. The effective tax rate for the three months ended March 27, 2021, diverged from the combined U.S. federal and state statutory tax rate, primarily because of income taxed at lower rates, the benefit of research credits and foreign tax credits, partially offset by foreign withholding taxes and GILTI.

The provision for income taxes of $32.3 million and $16.4 million for the nine months ended March 26, 2022 and March 27, 2021, respectively, represented estimated federal, foreign, and state income taxes. The effective tax rate for the nine months ended March 26, 2022 diverged from the combined U.S. federal and state statutory tax rate primarily because of income taxed at lower rates, the benefit of research credits and foreign tax credits, partially offset by foreign withholding taxes, non-deductible officer compensation and GILTI. The effective tax rate for the nine months ended March 27, 2021, diverged from the combined U.S. federal and state statutory tax rate, primarily because of the benefit of income taxed at lower rates, research credits and foreign tax credits, partially offset by foreign withholding taxes and GILTI.

The total liability for gross unrecognized tax benefits related to uncertain tax positions increased $14.4 million during the nine months ended March 26, 2022, to $37.0 million, and was included in other long-term liabilities on our condensed consolidated balance sheets. If recognized, the total gross unrecognized tax benefits would reduce the effective tax rate on income from continuing operations. Accrued interest and penalties related to unrecognized tax benefits as of March 26, 2022 were $2.7 million; this balance increased by $1.0 million compared to June 26, 2021. We classify interest and penalties as components of income tax expense. Any prospective adjustments to our unrecognized tax benefits will be recorded as an increase or decrease to income tax expense and cause a corresponding change to our effective tax rate. Accordingly, our effective tax rate could fluctuate materially from period to period.

Our major tax jurisdictions are the United States, Hong Kong SAR, Israel, Japan and the United Kingdom. From fiscal 2014 onward, we remain subject to examination by one or more of these jurisdictions.

In January 2022, final foreign tax credit regulations were issued by the U.S. Treasury modifying long established rules, including rules used in the determination of whether foreign taxes paid or accrued are creditable against U.S. income taxes. We are evaluating these new regulations and certain research and development capitalization rule changes, all effective beginning with our fiscal 2023, but anticipate our future provision for income taxes will be adversely affected.